Transcriptional regulation in model organisms: recent progress and clinical implications
- PMID: 31744421
- PMCID: PMC6893401
- DOI: 10.1098/rsob.190183
Transcriptional regulation in model organisms: recent progress and clinical implications
Abstract
In this review, we will summarize model organisms used by scientists in the laboratory, including Escherichia coli, yeast, Arabidopsis thaliana, nematodes, Drosophila, zebrafish, mice and other animals. We focus on the progress in research exploring different types of E. coli in the human body, and the specific molecular mechanisms by which they play a role in humans. First, we discuss the specific transcriptional regulation mechanism of E. coli in cell development, maturation, ageing and longevity, as well as tumorigenesis and development. Then, we discuss how the synthesis of some important substances in cells is regulated and how this affects biological behaviour. Understanding and applying these mechanisms, presumably, can greatly improve the quality of people's lives as well as increase their lifespan. For example, some E. coli can activate certain cells by secreting insulin-like growth factor-1, thus activating the inflammatory response of the body, while other E. coli can inactivate the immune response of the body by secreting toxic factors.
Keywords: Caenorhabditis elegans; Drosophila melanogaster; model organisms; transcriptional regulation.
Conflict of interest statement
We have no competing interests.
Figures




Similar articles
-
New opportunities at the wild frontier.Elife. 2015 Mar 25;4:e06956. doi: 10.7554/eLife.06956. Elife. 2015. PMID: 25806959 Free PMC article.
-
A gene network for navigating the literature.Nat Genet. 2004 Jul;36(7):664. doi: 10.1038/ng0704-664. Nat Genet. 2004. PMID: 15226743 No abstract available.
-
A general tendency for conservation of protein length across eukaryotic kingdoms.Mol Biol Evol. 2005 Jan;22(1):142-7. doi: 10.1093/molbev/msh263. Epub 2004 Sep 15. Mol Biol Evol. 2005. PMID: 15371528
-
Model organisms illuminate human genetics and disease.Mol Med. 1997 Apr;3(4):231-7. Mol Med. 1997. PMID: 9131585 Free PMC article. Review. No abstract available.
-
Aging and longevity genes.Acta Biochim Pol. 2000;47(2):269-79. Acta Biochim Pol. 2000. PMID: 11051192 Review.
Cited by
-
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.Int J Mol Sci. 2022 Jan 1;23(1):488. doi: 10.3390/ijms23010488. Int J Mol Sci. 2022. PMID: 35008915 Free PMC article. Review.
-
Microsatellite instability: a review of what the oncologist should know.Cancer Cell Int. 2020 Jan 13;20:16. doi: 10.1186/s12935-019-1091-8. eCollection 2020. Cancer Cell Int. 2020. PMID: 31956294 Free PMC article. Review.
-
Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients.Front Oncol. 2022 Jul 25;12:772102. doi: 10.3389/fonc.2022.772102. eCollection 2022. Front Oncol. 2022. PMID: 35957880 Free PMC article.
-
Three-dimensional genome: developmental technologies and applications in precision medicine.J Hum Genet. 2020 Jun;65(6):497-511. doi: 10.1038/s10038-020-0737-7. Epub 2020 Mar 9. J Hum Genet. 2020. PMID: 32152365
-
Mesenchymal stem cells: ideal seeds for treating diseases.Hum Cell. 2021 Nov;34(6):1585-1600. doi: 10.1007/s13577-021-00578-0. Epub 2021 Jul 16. Hum Cell. 2021. PMID: 34272720 Free PMC article. Review.
References
-
- Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. 2007. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb Vasc. Biol. 27, 2684–2690. (10.1161/ATVBAHA.107.156257) - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases